Aminomix N 1, Infusionslösung

7680504780931 CH-50478 Infusionslösung
Aminomix N 1, Infusionslösung
Aminomix N 1, Infusionslösung
1 / 2
google

Article details

Package size
4 x 1500
Selling units
4
Measure
ml
Galenic form
Infusionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
16/05/2022
Summary of Product Characteristics
Français
16/05/2022
Summary of Product Characteristics
Italien
16/05/2022

Detailed composition

Substance Quantity Type Category
I
2.5 G Substance Wirkstoff (Principe actif)
I
3.7 G Substance Wirkstoff (Principe actif)
I
3.3 G Substance Wirkstoff (Principe actif)
I
- Substance WIZUS
I
2.15 G Substance Wirkstoff (Principe actif)
I
2.55 G Substance Wirkstoff (Principe actif)
I
2.2 G Substance Wirkstoff (Principe actif)
I
1.0 G Substance Wirkstoff (Principe actif)
I
3.1 G Substance Wirkstoff (Principe actif)
I
0.2 G Substance Wirkstoff (Principe actif)
I
6.0 G Substance Wirkstoff (Principe actif)
I
1.5 G Substance Wirkstoff (Principe actif)
I
0.5 G Substance Wirkstoff (Principe actif)
I
5.5 G Substance Wirkstoff (Principe actif)
I
7.0 G Substance Wirkstoff (Principe actif)
I
5.6 G Substance Wirkstoff (Principe actif)
I
3.25 G Substance Wirkstoff (Principe actif)
I
4.59 G Substance Wirkstoff (Principe actif)
I
4.5 G Substance Wirkstoff (Principe actif)
I
1.98 G Substance Wirkstoff (Principe actif)
I
1.65 G Substance Wirkstoff (Principe actif)
I
- Substance HNIDK
II
200.0 G Substance Wirkstoff (Principe actif)
II
- Substance WIZUS
II
1.169 G Substance Wirkstoff (Principe actif)
II
294.0 MG Substance Wirkstoff (Principe actif)
II
0.61 G Substance Wirkstoff (Principe actif)
II
5.5 MG Substance Wirkstoff (Principe actif)
II
- Substance HNIDK
12C
50.0 GL Substance Wirkstoff (Principe actif)
12C
50.0 MMOLL Substance Wirkstoff (Principe actif)
12C
30.0 MMOLL Substance Wirkstoff (Principe actif)
12C
2.0 MMOLL Substance Wirkstoff (Principe actif)
12C
3.0 MMOLL Substance Wirkstoff (Principe actif)
12C
0.04 MMOLL Substance Wirkstoff (Principe actif)
12C
64.0 MMOLL Substance Wirkstoff (Principe actif)
12C
15.0 MMOLL Substance Wirkstoff (Principe actif)
12C
75.0 MMOLL Substance Wirkstoff (Principe actif)

Authorization holder

Fresenius Kabi (Schweiz) AG

6010 Kriens

Authorization information

Swissmedic authorization number
50478
Drug name
Aminomix N, Infusionslösung
Galenic form
LSPA
ATC Code
B05BA01
Authorization status
Z
Dispensing category
B
First authorization
17/11/1989
Authorization expiration date
31/12/9999
IT Number
07.01.2.
Domain
Human medicine
Field of application
Parenterale Ernährung

Package details

Description (FR)
AMINOMIX N 1 sol perf Biofine 4 sach 1500 ml
Description (DE)
AMINOMIX N 1 Inf Lös Biofine 4 Btl 1500 ml
Market launch
12/09/2008
Narcotic (BTM)
No

Other package sizes (10)

AMINOMIX 1 sol perf 6 sach 1000 ml
6 x 1000 ML
GTIN: 7680504780177
Not in V1
AMINOMIX 1 sol perf 4 sach 1500 ml
4 x 1500 ML
GTIN: 7680504780252
Not in V1
None
4 x 2000 ML
GTIN: None
Not in V1
AMINOMIX 2 sol perf 6 sach 1000 ml
6 x 1000 ML
GTIN: 7680504780412
Not in V1
AMINOMIX 2 sol perf 4 sach 1500 ml
4 x 1500 ML
GTIN: 7680504780689
Not in V1
None
4 x 2000 ML
GTIN: None
Not in V1
None
6 x 1000 ML
GTIN: None
Not in V1
AMINOMIX N 1 sol perf Biofine 6 sach 1000 ml
None None
GTIN: 7680504780924
Not in V1
AMINOMIX N 1 Biofine sol perf 4 sach 2000 ml
None None
GTIN: 7680504780948
Not in V1
AMINOMIX N 2 Biofine sol perf 6 sach 1000 ml
6 x 1000 ML
GTIN: 7680504780955
Not in V1